Clinical Trial Update: Pentabiocel in Pediatric IBS [NA]

View source ↗

Summary

Clinical trial update indicates that Pentabiocel for pediatric irritable bowel syndrome is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome

Drugs mentioned

• Pentabiocel

Snippet

Sponsor: University of Roma La Sapienza | Conditions: Irritable Bowel Syndrome (IBS), Pediatrics | NA | Status: NOT_YET_RECRUITING